Becker's Healthcare May 24, 2024
Cameron Cortigiano

An advisory committee to the FDA voted that a blood test that screens for colon and rectal cancers was safe, according to a May 23 report by The New York Times.

The test, designed by Guardant Health, offers an alternative to a colonoscopy or self-administered fecal test for individuals with an average risk for colon and rectal cancers.

However, blood tests are not as effective as colonoscopies at...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
To Give Rare Disease Patients Hope, the FDA Must Re-Focus its Efforts
Opinion: Adding psychotherapy to drug therapy works, but the FDA may not be able to handle it
FDA clears heart rhythm AI that turns smartphones into medical devices
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs
Accelerated Approval Pathway for Cancer Drugs: Does It Work?

Share This Article